These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

468 related items for PubMed ID: 23084789

  • 1. The use of dehydroepiandrosterone in the treatment of hypoactive sexual desire disorder: a report of gender differences.
    Bloch M, Meiboom H, Zaig I, Schreiber S, Abramov L.
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):910-8. PubMed ID: 23084789
    [Abstract] [Full Text] [Related]

  • 2. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Balser J.
    Menopause; 2009 Aug; 16(5):923-31. PubMed ID: 19424093
    [Abstract] [Full Text] [Related]

  • 3. Six-month oral dehydroepiandrosterone supplementation in early and late postmenopause.
    Stomati M, Monteleone P, Casarosa E, Quirici B, Puccetti S, Bernardi F, Genazzani AD, Rovati L, Luisi M, Genazzani AR.
    Gynecol Endocrinol; 2000 Oct; 14(5):342-63. PubMed ID: 11109974
    [Abstract] [Full Text] [Related]

  • 4. A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido.
    Panjari M, Bell RJ, Jane F, Wolfe R, Adams J, Morrow C, Davis SR.
    J Sex Med; 2009 Sep; 6(9):2579-90. PubMed ID: 19619146
    [Abstract] [Full Text] [Related]

  • 5. Effects of transdermal testosterone or oral dydrogesterone on hypoactive sexual desire disorder in transsexual women: results of a pilot study.
    Kronawitter D, Gooren LJ, Zollver H, Oppelt PG, Beckmann MW, Dittrich R, Mueller A.
    Eur J Endocrinol; 2009 Aug; 161(2):363-8. PubMed ID: 19497984
    [Abstract] [Full Text] [Related]

  • 6. Women with low libido: correlation of decreased androgen levels with female sexual function index.
    Turna B, Apaydin E, Semerci B, Altay B, Cikili N, Nazli O.
    Int J Impot Res; 2005 Aug; 17(2):148-53. PubMed ID: 15592425
    [Abstract] [Full Text] [Related]

  • 7. Efficacy of Tribulus Terrestris for the treatment of premenopausal women with hypoactive sexual desire disorder: a randomized double-blinded, placebo-controlled trial.
    Vale FBC, Zanolla Dias de Souza K, Rezende CR, Geber S.
    Gynecol Endocrinol; 2018 May; 34(5):442-445. PubMed ID: 29172782
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of Tribulus terrestris for the treatment of hypoactive sexual desire disorder in postmenopausal women: a randomized, double-blinded, placebo-controlled trial.
    de Souza KZ, Vale FB, Geber S.
    Menopause; 2016 Nov; 23(11):1252-1256. PubMed ID: 27760089
    [Abstract] [Full Text] [Related]

  • 9. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB.
    Arch Intern Med; 2005 Jul 25; 165(14):1582-9. PubMed ID: 16043675
    [Abstract] [Full Text] [Related]

  • 10. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
    Krapf JM, Simon JA.
    Maturitas; 2009 Jul 20; 63(3):213-9. PubMed ID: 19487090
    [Abstract] [Full Text] [Related]

  • 11. Sexual desire, sexual arousal and hormonal differences in premenopausal US and Dutch women with and without low sexual desire.
    Heiman JR, Rupp H, Janssen E, Newhouse SK, Brauer M, Laan E.
    Horm Behav; 2011 May 20; 59(5):772-9. PubMed ID: 21514299
    [Abstract] [Full Text] [Related]

  • 12. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: results from the INTIMATE NM1 Study.
    Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R.
    Menopause; 2006 May 20; 13(5):770-9. PubMed ID: 16932240
    [Abstract] [Full Text] [Related]

  • 13. Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.
    van Lunsen RHW, Zimmerman Y, Coelingh Bennink HJT, Termeer HMM, Appels N, Fauser BCJM, Laan E.
    Contraception; 2018 Jul 20; 98(1):56-62. PubMed ID: 29490289
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
    Davis SR, van der Mooren MJ, van Lunsen RH, Lopes P, Ribot C, Rees M, Moufarege A, Rodenberg C, Buch A, Purdie DW.
    Menopause; 2006 Jul 20; 13(3):387-96. PubMed ID: 16735935
    [Abstract] [Full Text] [Related]

  • 15. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens.
    Arlt W, Haas J, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B.
    J Clin Endocrinol Metab; 1999 Jun 20; 84(6):2170-6. PubMed ID: 10372727
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: a double-blind, placebo controlled study.
    Berman JR, Berman LA, Toler SM, Gill J, Haughie S, Sildenafil Study Group.
    J Urol; 2003 Dec 20; 170(6 Pt 1):2333-8. PubMed ID: 14634409
    [Abstract] [Full Text] [Related]

  • 17. Lack of influence of dyspareunia on the beneficial effect of intravaginal prasterone (dehydroepiandrosterone, DHEA) on sexual dysfunction in postmenopausal women.
    Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez JL, Girard G, Baron M, Ayotte N, Moreau M, Dubé R, Côté I, Labrie C, Lavoie L, Gilbert L, Martel C, Balser J.
    J Sex Med; 2014 Jul 20; 11(7):1766-85. PubMed ID: 24774442
    [Abstract] [Full Text] [Related]

  • 18. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial.
    Hunt PJ, Gurnell EM, Huppert FA, Richards C, Prevost AT, Wass JA, Herbert J, Chatterjee VK.
    J Clin Endocrinol Metab; 2000 Dec 20; 85(12):4650-6. PubMed ID: 11134123
    [Abstract] [Full Text] [Related]

  • 19. Androgen replacement therapy with dehydroepiandrosterone for androgen insufficiency and female sexual dysfunction: androgen and questionnaire results.
    Munarriz R, Talakoub L, Flaherty E, Gioia M, Hoag L, Kim NN, Traish A, Goldstein I, Guay A, Spark R.
    J Sex Marital Ther; 2002 Dec 20; 28 Suppl 1():165-73. PubMed ID: 11898698
    [Abstract] [Full Text] [Related]

  • 20. Effects of a two-week physiological dehydroepiandrosterone substitution on cognitive performance and well-being in healthy elderly women and men.
    Wolf OT, Neumann O, Hellhammer DH, Geiben AC, Strasburger CJ, Dressendörfer RA, Pirke KM, Kirschbaum C.
    J Clin Endocrinol Metab; 1997 Jul 20; 82(7):2363-7. PubMed ID: 9215320
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.